Keyphrases
Graft-versus-host Disease (GvHD)
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
54%
Hematopoietic Cell Transplantation
26%
Confidence Interval
19%
Clinical Outcomes
15%
Reduced-intensity Conditioning
13%
Overall Survival
13%
Non-relapse Mortality
12%
Acute Leukemia
12%
Mycophenolate Mofetil
11%
Bone Marrow
10%
Unrelated Donor
10%
Peripheral Blood
10%
Relapse-free Survival
10%
Myelodysplastic Syndrome
10%
Microbiota
9%
Gut Microbiota
8%
Graft-versus-host Disease Prophylaxis
8%
Umbilical Cord Blood Transplantation
8%
Amphiregulin
7%
Disease-free
7%
Umbilical Cord Blood
7%
Angiogenic Factors
7%
Total Body Irradiation
7%
High Risk
7%
Pretransplant
7%
Myeloablative
6%
Phase II Trial
6%
Melanoma
6%
Marrow Transplantation
6%
Sirolimus
6%
Lymphocytes
6%
Hematological Malignancies
6%
Clinical Trials Network
6%
Metastatic Melanoma
6%
Total Marrow Irradiation
6%
Monocytes
6%
Transplantation
6%
Acute Myeloid Leukemia
6%
Disease Risk Prediction
6%
Steroid-refractory Acute Graft-versus-host Disease
6%
Fecal Microbiota Transplantation
6%
Clinical Trials
6%
Epidermal Growth Factor
5%
Hazard Ratio
5%
GVHD-free Relapse-free Survival
5%
Tacrolimus
5%
Disease Progression
5%
Hematopoietic Stem Cell Transplantation
5%
Odds Ratio
5%
Immunology and Microbiology
Graft-Versus-Host Disease
64%
Hematopoietic Cell
57%
Cell Transplantation
54%
Acute Graft Versus Host Disease
50%
Chronic Graft Versus Host Disease
24%
Conditioning
16%
Overall Survival
15%
Microflora
12%
Mycophenolate Mofetil
12%
Umbilical Cord Blood
11%
Recurrence Free Survival
10%
Intestine Flora
10%
Lymphocyte
8%
Allograft
8%
Immunity
7%
Amphiregulin
7%
Cyclophosphamide
7%
Engraftment
7%
Angiogenic Factor
7%
Sirolimus
7%
Feces microflora
6%
Tacrolimus
5%
Epidermal Growth Factor
5%
Lymphocyte Count
5%
Myeloid
5%
Hematopoietic Stem Cell Transplantation
5%
Medicine and Dentistry
Graft Versus Host Reaction
40%
Hematopoietic Cell
37%
Cell Transplantation
33%
Acute Graft Versus Host Disease
20%
Transplantation
15%
Malignant Neoplasm
14%
Chronic Graft Versus Host Disease
12%
Myelodysplastic Syndrome
10%
Overall Survival
9%
Cord Blood
9%
Lymphocyte
8%
Whole Body Radiation
8%
Melanoma
8%
Disease
8%
Acute Leukemia
7%
Amphiregulin
7%
Gut Microbiota
6%
Recurrence Free Survival
6%
Immunity
6%
Clinical Trial
6%
Reduced Intensity Conditioning
5%
Acute Myeloid Leukemia
5%
Prophylaxis
5%
Conditioning
5%
Rapamycin
5%